At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Grant Writing Mini Course – Registration Deadline Today!
- New Jersey coasts, lined with toxic facilities, don’t fare well in two new studies.
- Translational Science Competency-Based Assessment Pilot Test Sign Up
- As few as 2 cigarettes per day linked to 50% increased risk of heart disease: Study
- What You Need to Know About ‘Ozempic Face,’ According to Doctors.
Categories
- Community (2,404)
- Covid (993)
- CTO Events (6)
- News (3,046)
- Pilots (21)